| Cash Flow | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 |
|---|---|---|---|---|
| Impairment charge | NaN | 0 | 0 | 0 |
| Net income | 32,584 | 47,343 | 45,851 | 84,493 |
| Depreciation and amortization | 4,574 | 4,461 | 2,488 | 10,522 |
| Stock-based compensation | 14,645 | 15,262 | 15,932 | 28,019 |
| Inventory write-downs | 1,634 | 1,536 | 973 | 3,260 |
| Deferred taxes | -727 | 15,060 | 14,721 | -8,747 |
| Acquired in-process research and development | NaN | 0 | NaN | NaN |
| Other | -1,211 | -741 | 303 | 643 |
| Accounts receivable | -5,542 | 6,824 | 8,451 | 4,239 |
| Inventories | 9,019 | 630 | 3,719 | 22,133 |
| Prepaid expenses and other current and non-current assets | -13,040 | -4,403 | 17,186 | -86 |
| Accounts payable | 8,966 | 4,538 | 2,029 | -3,500 |
| Accrued expenses and other non-current liabilities | 16,943 | 2,076 | 5,322 | 5,512 |
| Proceeds from lease incentives | NaN | 0 | NaN | NaN |
| Net cash provided by operating activities | 86,971 | 86,484 | 58,263 | 93,916 |
| Asset acquisition, net of cash acquired | NaN | 0 | NaN | NaN |
| Purchases of non-marketable investments | NaN | 0 | 0 | 0 |
| Purchases of marketable investments | 141,101 | 209,089 | 146,612 | 36 |
| Proceeds from sales of marketable investments | NaN | 1,876 | NaN | NaN |
| Proceeds from maturities of marketable investments | 125,139 | 0 | 0 | 13,000 |
| Purchases of property and equipment | 13,671 | 18,434 | 16,249 | 29,046 |
| Other | 1,000 | 0 | 0 | 0 |
| Net cash used in investing activities | -30,633 | -225,647 | -162,861 | -16,082 |
| Proceeds from issuance of stock under employee stock purchase plan | NaN | 7,542 | 0 | 8,866 |
| Proceeds from exercises of stock options | 0 | 33 | 4,652 | 10,726 |
| Payment of employee taxes related to vested stock | 1,290 | 1,949 | 90 | 507 |
| Payments of finance lease obligations | 617 | 569 | 612 | 1,304 |
| Repurchase of common stock | NaN | 0 | 0 | NaN |
| Other | 0 | 0 | 0 | -256 |
| Net cash (used in) provided by financing activities | -1,907 | 5,057 | 3,950 | 17,525 |
| Effect of foreign exchange rate changes on cash and cash equivalents | -39 | -26 | -91 | 2,005 |
| Net increase in cash and cash equivalents | 54,392 | -134,132 | -100,739 | 97,364 |
| Cash and cash equivalentsbeginning of period | 186,897 | 3,375 | 324,404 | NaN |
| Cash and cash equivalentsend of period | 241,289 | -134,132 | 321,029 | NaN |
Penumbra Inc (PEN)
Penumbra Inc (PEN)